Kingswood Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Buy
6,385
+1,288
+25% +$441K 0.09% 228
2026
Q1
$1.79M Buy
5,097
+158
+3% +$56.3K 0.09% 257
2025
Q4
$1.62M Buy
4,939
+1,027
+26% +$326K 0.08% 253
2025
Q3
$1.1M Buy
3,912
+640
+20% +$186K 0.07% 303
2025
Q2
$914K Buy
3,272
+72
+2% +$20.4K 0.07% 280
2025
Q1
$996K Sell
3,200
-245
-7% -$72.3K 0.09% 244
2024
Q4
$898K Sell
3,445
-4,499
-57% -$1.33M 0.07% 296
2024
Q3
$2.56M Buy
7,944
+1,211
+18% +$396K 0.18% 122
2024
Q2
$2.1M Buy
6,733
+122
+2% +$35.8K 0.19% 111
2024
Q1
$1.88M Sell
6,611
-183
-3% -$53.5K 0.22% 115
2023
Q4
$1.96M Buy
6,794
+5,237
+336% +$1.43M 0.22% 104
2023
Q3
$1.68M Sell
1,557
-593
-28% -$148K 0.29% 90
2023
Q2
$478K Buy
+2,150
New +$499K 0.15% 142

Other funds holding AMGN

Kingswood Wealth Advisors's AMGN Position: Q2 2026 in Review

Kingswood Wealth Advisors increased its Amgen (AMGN) stake by 25% in Q2 2026, buying an estimated $441K and bringing the position to 6,385 shares worth $2.31M. The position accounts for 0.09% of the portfolio, ranked #228.

Kingswood Wealth Advisors first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.56M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kingswood Wealth Advisors held 6,385 shares of Amgen worth $2.31M as of Q2 2026.
  • Kingswood Wealth Advisors bought 1,288 Amgen shares in Q2 2026, an estimated $441K.
  • Amgen made up 0.09% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #228 holding.
  • Kingswood Wealth Advisors first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • Kingswood Wealth Advisors's Amgen position peaked at $2.56M in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.